MARKET

BPMX

BPMX

BIOPHARMX
AMEX

Real-time Quotes | Nasdaq Last Sale

0.2684
-0.0076
-2.75%
After Hours: 0.2750 +0.0066 +2.46% 17:51 04/03 EDT
OPEN
0.2750
PREV CLOSE
0.2760
HIGH
0.2900
LOW
0.2650
VOLUME
385.01K
TURNOVER
--
52 WEEK HIGH
2.700
52 WEEK LOW
0.2500
MARKET CAP
4.91M
P/E (TTM)
-0.3235
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BPMX stock price target is 2.250 with a high estimate of 2.250 and a low estimate of 2.250.

EPS

BPMX News

More
  • BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain Trading
  • PR Newswire · 03/25 21:15
  • Pharma Two B Appoints David S. Tierney, M.D. as the Companys Chief Executive Officer
  • GlobeNewswire · 02/18 13:00
  • AT&T will likely be broken up and will move on from WarnerMedia, analyst Craig Moffett predicts
  • CNBC.com · 01/30 20:22
  • AT&T headed for breakup in time - Moffett
  • Seeking Alpha - Article · 01/30 16:17

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About BPMX

BioPharmX Corporation is a specialty pharmaceutical company. The Company is focused on utilizing its drug delivery technologies to develop and commercialize prescription and over-the-counter (OTC) products that address markets in women's health and dermatology. Its portfolio of product candidates includes two clinical stage product candidates: BPX01, which is a topical antibiotic for the treatment of acne based on a formulation of minocycline, and BPX03, which is a molecular iodine (I2) tablet for the treatment of benign breast pain associated with fibrocystic breast condition (FBC) and cyclic mastalgia. Its VI2OLET is an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort and is clinically demonstrated to alleviate the symptoms associated with FBC, including tenderness, aches and swelling. It is developing BPX02, which is an injectable utilizing biologic materials for aesthetic dermatology applications.
More

Webull offers kinds of Biopharmx Corp stock information, including AMEX:BPMX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BPMX stock news, and many more online research tools to help you make informed decisions.